Blood transfusion of transfusing uncrossmatched blood, O-negative blood is used, followed by crossmatch as soon as possible. O-negative is also used for children and women of childbearing age. It is preferable for the laboratory to obtain a pre-transfusion sample in these cases so a type and screen can be performed to determine the actual blood group of the patient and to check for alloantibodies. This chart shows possible matches in blood transfusion between donor and receiver using ABO and Rh system. In the same way that the safety of pharmaceutical products is overseen by pharmacovigilance, the safety of blood and blood products
ABO blood group system it is more likely that the force driving evolution of allele diversity is simply negative frequency-dependent selection; cells with rare variants of membrane antigens are more easily distinguished by the immune system from pathogens carrying antigens from other hosts. Thus, individuals possessing rare types are better equipped to detect pathogens. The high within-population diversity observed in human populations would, then, be a consequence of natural selection on individuals. HIV can be neutralized in "in vitro" experiments using antibodies against blood group antigens specifically expressed on the HIV-producing cell lines. The carbohydrate molecules on the surfaces of red blood cells have